Germline Mutations and Phenotypic Associations in Korean Patients With Pheochromocytoma and Paraganglioma: A Multicenter Study and Literature Review
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Genetic testing is recommended for all patients with pheochromocytomas and paragangliomas (PPGL) to establish genotype–phenotype associations. We investigated germline mutations in 59 patients with PPGL at six Korean university hospitals using next-generation sequencing (NGS) targeting 38 PPGL-associated genes, including those recommended by the Korean PPGL Task Force. Germline mutations were identified in 13 patients (22%), and affected four genes: RET, NF1, VHL, and SDHD. Germline mutations were significantly associated with a family history of PPGL, smaller tumor size, and the presence of other types of tumors. Using 95 Korean PPGL cases with germline mutations identified through a literature review and 13 cases from our cohort, we characterized genotype–phenotype correlations. Mutation hotspots were identified in specific codons of RET (codons 631 and 634), VHL (157 and 167), and SDHB (131 and 253). NF1 mutations varied, indicating the absence of common hotspots. These findings highlight the efficacy of the recommended NGS panel for Korean patients with PPGL and the importance of genetic testing in establishing clinical management and personalized therapeutic strategies.
Abstract
Genetic testing is recommended for all patients with pheochromocytomas and paragangliomas (PPGL) to establish genotype–phenotype associations. We investigated germline mutations in 59 patients with PPGL at six Korean university hospitals using next-generation sequencing (NGS) targeting 38 PPGL-associated genes, including those recommended by the Korean PPGL Task Force. Germline mutations were identified in 13 patients (22%), and affected four genes: RET, NF1, VHL, and SDHD. Germline mutations were significantly associated with a family history of PPGL, smaller tumor size, and the presence of other types of tumors. Using 95 Korean PPGL cases with germline mutations identified through a literature review and 13 cases from our cohort, we characterized genotype–phenotype correlations. Mutation hotspots were identified in specific codons of RET (codons 631 and 634), VHL (157 and 167), and SDHB (131 and 253). NF1 mutations varied, indicating the absence of common hotspots. These findings highlight the efficacy of the recommended NGS panel for Korean patients with PPGL and the importance of genetic testing in establishing clinical management and personalized therapeutic strategies.
참고문헌 (19)
- Lam AK, "Update on adrenal tumours in 2017 World Health Organization(WHO)of endocrine tumours", Endocr Pathol, 28, pp.213~227 (2017)
- Qing T, "Germline variant burden in cancer genes correlates with age at diagnosis and somatic mutation burden", Nat Commun, 11, pp.2438~ (2020)
- Buffet A, "Pheochromocytoma : when to search a germline defect?", Presse Med, 47, pp.e109~e118 (2018)
- Dahia PL, "Pheochromocytoma and paraganglioma pathogenesis : learning from genetic heterogeneity", Nat Rev Cancer, 14, pp.108~119 (2014)
- NGS in PPGL(NGSnPPGL)Study Group, "Consensus Statement on next-generation-sequencing-based diagnostic testing of hereditary phaeochromocytomas and paragangliomas", Nat Rev Endocrinol, 13, pp.233~247 (2017)
- Kim JH, "Germline mutations and genotype-phenotype correlations in patients with apparently sporadic pheochromocytoma", paraganglioma in Korea, 2014, pp.86, 482~486
- Ku EJ, "Diagnosis for pheochromocytoma and paraganglioma : a joint position statement of the Korean pheochromocytoma and paraganglioma task force", Endocrinol Metab(Seoul), 36, pp.322~338 (2021)
- Yonamine M, "Prevalence of germline Variants in a Large Cohort of Japanese Patients with pheochromocytoma and", or paraganglioma, 2021, pp.13, ~
- Gimenez-Roqueplo AP, "Mutations in the SDHB gene are associated with extra-adrenal and", or malignant phaeochromocytomas, 2003, pp.63, 5615~5621
- Liu P, "Clinical syndromes and genetic screening strategies of pheochromocytoma and paraganglioma", J Kidney Cancer VHL, 5, pp.14~22 (2018)
- Kim JH, "Characteristics of germline mutations in Korean patients with pheochromocytoma", paraganglioma, 2022, pp.59, 56~64
- Choi H, "Genetic analysis and clinical characteristics of hereditary pheochromocytoma and paraganglioma syndrome in Korean population", Endocrinol Metab(Seoul), 35, pp.858~872 (2020)
- Seo SH, "Whole exome sequencing identifies novel genetic alterations in patients with pheochromocytoma", paraganglioma, 2020, pp.35, 909~917
- Crona J, "New perspectives on pheochromocytoma and paraganglioma : toward a molecular classification", Endocr Rev, 38, pp.489~515 (2017)
- Richards S, "Standards and guidelines for the interpretation of sequence variants : a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology", Genet Med, 17, pp.405~424 (2015)
- Amar L, "Genetic testing in pheochromocytoma or functional paraganglioma", J Clin Oncol, 23, pp.8812~8818 (2005)
- Cascón A, "Genetics of pheochromocytoma and paraganglioma in Spanish patients", J Clin Endocrinol Metab, 94, pp.1701~1705 (2009)
- Pandit R, "Germline mutations and genotype-phenotype correlation in Asian Indian patients with pheochromocytoma and paraganglioma", Eur J Endocrinol, 175, pp.311~323 (2016)
- Currás-Freixes M, "PheoSeq : A targeted next-generation sequencing assay for pheochromocytoma and paraganglioma diagnostics", J Mol Diagn, 19, pp.575~588 (2017)